ConductScience.org, home

Paper349090

Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli.

Kunst MW and 1 other. J Infect Dis, 1978. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli. Papers, record 349090. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/349090

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli.
PubMed
Journal
J Infect Dis
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kunst MWM W
2Mattie HH

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CefazolinMajor topic
CephalosporinsMajor topic
CephradineMajor topic
Escherichia coliMajor topic
Animals
Blood Bactericidal Activity
Dose-Response Relationship, Drug
Escherichia coli Infections
Male
Mice
Microbial Sensitivity Tests
Protein Binding

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
24514089Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24514089PubMed
9788972Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation.J Clin Invest1998https://conductscience.org/library/papers/9788972PubMed
9536121Effect of granulocyte-macrophage colony-stimulating factor on the number of leucocytes and course of Listeria monocytogenes infection in naive and leucocytopenic mice.Immunology1998https://conductscience.org/library/papers/9536121PubMed
8668686Pharmacokinetic-pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro.Pharm Res1996https://conductscience.org/library/papers/8668686PubMed
7352755Hydrolysis of 3-acetoxymethyl cephalosporins by lysed whole blood.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7352755PubMed
7004338Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7004338PubMed
6995305Effects of immunization and anticoagulation on the development of experimental Escherichia coli endocarditis.Infect Immun1980https://conductscience.org/library/papers/6995305PubMed
6712203Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6712203PubMed
6231249Quantitative determination of the effect of granulocytes on the course of experimental infections during antibiotic treatment.Infection1984https://conductscience.org/library/papers/6231249PubMed
3957435Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.Infection1986https://conductscience.org/library/papers/3957435PubMed
3924086Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3924086PubMed
3612501The relation between plasma and tissue concentrations of antibiotics. Description of a method.J Pharmacokinet Biopharm1987https://conductscience.org/library/papers/3612501PubMed
3196009Antibacterial effect of etoposide in vitro.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3196009PubMed
2764550Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2764550PubMed
2291658Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2291658PubMed
2039191Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2039191PubMed
1489186Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1489186PubMed
389823Clinical pharmacological evaluation of aminopenicillins.Infection1979https://conductscience.org/library/papers/389823PubMed
389820Influence of aminopenicillins on bacterial growth kinetics in vitro in comparison with the antibacterial effect in vivo.Infection1979https://conductscience.org/library/papers/389820PubMed
370021Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.Infection1979https://conductscience.org/library/papers/370021PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/349090

GET https://conductscience.org/api/papers/v1/349090/cited_by?page=2